Fig. 1From: Prospective participant selection and ranking to maximize actionable pharmacogenetic variants and discovery in the eMERGE NetworkPGx Variants by Participants (27 Genes). Distributions of total variants, high-moderate impact coding variants, and total variants for the following genes: 1. CACNA1S and RYR1 (malignant hyperthermia); 2. SCN5A, KCNH2, and RYR2 (arrhythmia); and 3. LDLR (high cholesterol)Back to article page